{"id":37964,"date":"2013-06-05T00:00:00","date_gmt":"2013-06-04T23:00:00","guid":{"rendered":"http:\/\/www.pcb.ub.edu\/\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\/"},"modified":"2020-11-16T16:18:18","modified_gmt":"2020-11-16T15:18:18","slug":"cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer","status":"publish","type":"post","link":"https:\/\/www.pcb.ub.edu\/es\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\/","title":{"rendered":"Cinco institutos y farmac\u00e9uticas europeos se al\u00edan contra el c\u00e1ncer"},"content":{"rendered":"<p>\u00bb<\/p>\n<div class=\"col-sm-6 detall-noticia-imatges\">\n<div class=\"row\">\n<div class=\"item active one-image\">\n\t\t\t\t\t\t<a class=\"icon-search\" href='http:\/\/www.pcb.ub.edu\/\/wp-content\/uploads\/2020\/11\/1370421734963.jpg'><\/a><br \/>\n\t\t\t\t\t\t<img src='http:\/\/www.pcb.ub.edu\/\/wp-content\/uploads\/2020\/11\/1370421734963.jpg' \/>\n\t\t\t\t\t<\/div><\/div><\/div>\n<p>\t\t\t El consorcio recibir\u00e1 un financiamiento de seis millones de euros dentro del \u00e1rea de Salud del 7\u00ba Programa Marco de la Uni\u00f3n Europea. El Institut de Recerca Biom\u00e8dica (IRB Barcelona), a trav\u00e9s del grupo del investigador ICREA Eduard Batlle, forma parte del proyecto, conjuntamente con los institutos de referencia Wellcome Trust Sanger Institute (Reino Unido) y Hubrecht Institute (Pa\u00edses Bajos), y las empresas farmac\u00e9uticas holandesas OcellO B.V. y Merus B. V., esta \u00faltima ejerciendo de coordinadora. <\/p>\n<p> Suppresstem abordar\u00e1 a partir de junio y hasta el 2016 los mecanismos que permiten a las c\u00e9lulas madre tumorales resistir a la acci\u00f3n de los f\u00e1rmacos y sobrevivir a los tratamientos, un problema que ha hecho fracasar muchas terapias en el pasado. Adem\u00e1s, ser\u00e1 pionero en el uso de tejidos derivados del paciente en el desarrollo de los f\u00e1rmacos. El avance ser\u00e1 \u00fatil para predecir con m\u00e1s exactitud des del laboratorio si un f\u00e1rmaco podr\u00e1 funcionar en enfermos. Cuando est\u00e9 puesta a punto, esta t\u00e9cnica podr\u00e1 aplicarse a otros tipos de c\u00e1ncer y enfermedades. <\/p>\n<p> Dentro del consorcio, el equipo de Batlle ser\u00e1 el responsable de hacer el estudio inicial de las muestras extra\u00eddas de los pacientes y despu\u00e9s probar si los anticuerpos funcionan en ratones. Una vez identificados los mejores candidatos tendr\u00e1n que investigar los mecanismos de acci\u00f3n para acabar de perfeccionarlos. Los objetivos generales del consorcio son encontrar nuevos tratamientos del c\u00e1ncer y establecer una nueva estrategia que permita saber si un medicamento es eficaz antes de arrancar los ensayos cl\u00ednicos, donde son necesarias inversiones multimillonarias. <\/p>\n<p> <a href=\"http:\/\/www.irbbarcelona.org\/index.php\/es\/news\/irb-news\/scientific\/suppresstem-five-institutes-and-pharmaceutical-companies-join-forces-against-cancer\" target=\"_blank\" class=\"email\" rel=\"noopener noreferrer\">Enlace a la noticia [+]<\/a>  <\/p>\n","protected":false},"excerpt":{"rendered":"<p>Europa ha dado luz verde al consorcio Suppresstem para validar nuevos tratamientos contra el c\u00e1ncer colorrectal, el tercer tipo de c\u00e1ncer m\u00e1s frecuente en el mundo. El objetivo es encontrar anticuerpos terap\u00e9uticos dirigidos de manera exclusiva a las c\u00e9lulas madre del c\u00e1ncer colorrectal, las encargadas de impulsar el crecimiento del tumor. El consorcio recibir\u00e1 un financiamiento de seis millones de euros dentro del \u00e1rea de Salud del 7\u00ba Programa Marco de la Uni\u00f3n Europea.<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"inline_featured_image":false,"footnotes":""},"categories":[9],"tags":[],"class_list":["post-37964","post","type-post","status-publish","format-standard","category-sin-categorizar"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v28.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Cinco institutos y farmac\u00e9uticas europeos se al\u00edan contra el c\u00e1ncer - Parc Cient\u00edfic de Barcelona<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.pcb.ub.edu\/es\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Cinco institutos y farmac\u00e9uticas europeos se al\u00edan contra el c\u00e1ncer - Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"og:description\" content=\"Europa ha dado luz verde al consorcio Suppresstem para validar nuevos tratamientos contra el c\u00e1ncer colorrectal, el tercer tipo de c\u00e1ncer m\u00e1s frecuente en el mundo. El objetivo es encontrar anticuerpos terap\u00e9uticos dirigidos de manera exclusiva a las c\u00e9lulas madre del c\u00e1ncer colorrectal, las encargadas de impulsar el crecimiento del tumor. El consorcio recibir\u00e1 un financiamiento de seis millones de euros dentro del \u00e1rea de Salud del 7\u00ba Programa Marco de la Uni\u00f3n Europea.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.pcb.ub.edu\/es\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\/\" \/>\n<meta property=\"og:site_name\" content=\"Parc Cient\u00edfic de Barcelona\" \/>\n<meta property=\"article:published_time\" content=\"2013-06-04T23:00:00+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-11-16T15:18:18+00:00\" \/>\n<meta property=\"og:image\" content=\"http:\/\/www.pcb.ub.edu\/\/wp-content\/uploads\/2020\/11\/1370421734963.jpg\" \/>\n<meta name=\"author\" content=\"adminpcb\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"adminpcb\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\\\/\"},\"author\":{\"name\":\"adminpcb\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/d13cab05cd0a75b17fddca8496481021\"},\"headline\":\"Cinco institutos y farmac\u00e9uticas europeos se al\u00edan contra el c\u00e1ncer\",\"datePublished\":\"2013-06-04T23:00:00+00:00\",\"dateModified\":\"2020-11-16T15:18:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\\\/\"},\"wordCount\":289,\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/www.pcb.ub.edu\\\/\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/1370421734963.jpg\",\"articleSection\":[\"Sin categorizar\"],\"inLanguage\":\"es\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\\\/\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\\\/\",\"name\":\"Cinco institutos y farmac\u00e9uticas europeos se al\u00edan contra el c\u00e1ncer - Parc Cient\u00edfic de Barcelona\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\\\/#primaryimage\"},\"thumbnailUrl\":\"http:\\\/\\\/www.pcb.ub.edu\\\/\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/1370421734963.jpg\",\"datePublished\":\"2013-06-04T23:00:00+00:00\",\"dateModified\":\"2020-11-16T15:18:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/d13cab05cd0a75b17fddca8496481021\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\\\/#primaryimage\",\"url\":\"http:\\\/\\\/www.pcb.ub.edu\\\/\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/1370421734963.jpg\",\"contentUrl\":\"http:\\\/\\\/www.pcb.ub.edu\\\/\\\/wp-content\\\/uploads\\\/2020\\\/11\\\/1370421734963.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Cinco institutos y farmac\u00e9uticas europeos se al\u00edan contra el c\u00e1ncer\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#website\",\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/\",\"name\":\"Parc Cient\u00edfic de Barcelona\",\"description\":\"Universitat de Barcelona\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/#\\\/schema\\\/person\\\/d13cab05cd0a75b17fddca8496481021\",\"name\":\"adminpcb\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g\",\"caption\":\"adminpcb\"},\"url\":\"https:\\\/\\\/www.pcb.ub.edu\\\/es\\\/author\\\/adminpcb\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Cinco institutos y farmac\u00e9uticas europeos se al\u00edan contra el c\u00e1ncer - Parc Cient\u00edfic de Barcelona","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.pcb.ub.edu\/es\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\/","og_locale":"es_ES","og_type":"article","og_title":"Cinco institutos y farmac\u00e9uticas europeos se al\u00edan contra el c\u00e1ncer - Parc Cient\u00edfic de Barcelona","og_description":"Europa ha dado luz verde al consorcio Suppresstem para validar nuevos tratamientos contra el c\u00e1ncer colorrectal, el tercer tipo de c\u00e1ncer m\u00e1s frecuente en el mundo. El objetivo es encontrar anticuerpos terap\u00e9uticos dirigidos de manera exclusiva a las c\u00e9lulas madre del c\u00e1ncer colorrectal, las encargadas de impulsar el crecimiento del tumor. El consorcio recibir\u00e1 un financiamiento de seis millones de euros dentro del \u00e1rea de Salud del 7\u00ba Programa Marco de la Uni\u00f3n Europea.","og_url":"https:\/\/www.pcb.ub.edu\/es\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\/","og_site_name":"Parc Cient\u00edfic de Barcelona","article_published_time":"2013-06-04T23:00:00+00:00","article_modified_time":"2020-11-16T15:18:18+00:00","og_image":[{"url":"http:\/\/www.pcb.ub.edu\/\/wp-content\/uploads\/2020\/11\/1370421734963.jpg","type":"","width":"","height":""}],"author":"adminpcb","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"adminpcb","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.pcb.ub.edu\/es\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\/#article","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\/"},"author":{"name":"adminpcb","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/d13cab05cd0a75b17fddca8496481021"},"headline":"Cinco institutos y farmac\u00e9uticas europeos se al\u00edan contra el c\u00e1ncer","datePublished":"2013-06-04T23:00:00+00:00","dateModified":"2020-11-16T15:18:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\/"},"wordCount":289,"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\/#primaryimage"},"thumbnailUrl":"http:\/\/www.pcb.ub.edu\/\/wp-content\/uploads\/2020\/11\/1370421734963.jpg","articleSection":["Sin categorizar"],"inLanguage":"es"},{"@type":"WebPage","@id":"https:\/\/www.pcb.ub.edu\/es\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\/","url":"https:\/\/www.pcb.ub.edu\/es\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\/","name":"Cinco institutos y farmac\u00e9uticas europeos se al\u00edan contra el c\u00e1ncer - Parc Cient\u00edfic de Barcelona","isPartOf":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.pcb.ub.edu\/es\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\/#primaryimage"},"image":{"@id":"https:\/\/www.pcb.ub.edu\/es\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\/#primaryimage"},"thumbnailUrl":"http:\/\/www.pcb.ub.edu\/\/wp-content\/uploads\/2020\/11\/1370421734963.jpg","datePublished":"2013-06-04T23:00:00+00:00","dateModified":"2020-11-16T15:18:18+00:00","author":{"@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/d13cab05cd0a75b17fddca8496481021"},"breadcrumb":{"@id":"https:\/\/www.pcb.ub.edu\/es\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.pcb.ub.edu\/es\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.pcb.ub.edu\/es\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\/#primaryimage","url":"http:\/\/www.pcb.ub.edu\/\/wp-content\/uploads\/2020\/11\/1370421734963.jpg","contentUrl":"http:\/\/www.pcb.ub.edu\/\/wp-content\/uploads\/2020\/11\/1370421734963.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.pcb.ub.edu\/es\/cinco-institutos-y-farmaceuticas-europeos-se-alian-contra-el-cancer\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.pcb.ub.edu\/es\/"},{"@type":"ListItem","position":2,"name":"Cinco institutos y farmac\u00e9uticas europeos se al\u00edan contra el c\u00e1ncer"}]},{"@type":"WebSite","@id":"https:\/\/www.pcb.ub.edu\/es\/#website","url":"https:\/\/www.pcb.ub.edu\/es\/","name":"Parc Cient\u00edfic de Barcelona","description":"Universitat de Barcelona","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.pcb.ub.edu\/es\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Person","@id":"https:\/\/www.pcb.ub.edu\/es\/#\/schema\/person\/d13cab05cd0a75b17fddca8496481021","name":"adminpcb","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/41ad0fab4bb3bf5348b0af9612159cfd93173a57bbca98fecb50fa6f3ab97d28?s=96&d=mm&r=g","caption":"adminpcb"},"url":"https:\/\/www.pcb.ub.edu\/es\/author\/adminpcb\/"}]}},"_links":{"self":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/37964","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/comments?post=37964"}],"version-history":[{"count":1,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/37964\/revisions"}],"predecessor-version":[{"id":44141,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/posts\/37964\/revisions\/44141"}],"wp:attachment":[{"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/media?parent=37964"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/categories?post=37964"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.pcb.ub.edu\/es\/wp-json\/wp\/v2\/tags?post=37964"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}